Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir versus vitamin C in adults with HTLV-1 infection
RBR-5x7ccxpPhase 2Recruiting
- Sponsor
- Fundação Bahiana de Infectologia
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dolutegravir in human T-cell lymphotropic virus type 1 infection (HTLV-1) (2 arms), sponsored by Fundação Bahiana de Infectologia. Primary endpoint: Primary outcome assessment timepoint. Started Jul 2021; status: recruiting.
02
Drugs
dolutegravir
03
Conditions
human T-cell lymphotropic virus type 1 infection (HTLV-1)
Beyond the preview
Go deeper on RBR-5x7ccxp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5x7ccxp.